06-09-2024
Zenas BioPharma Inc., a Waltham, Mass.-based developer of immunology-based therapies, on Friday said it plans to offer 11.76 million shares of common stock at an estimated price range of $16 to $18 in its upcoming initial public offering.
06-09-2024
The Omaha-based conglomerate hit a record high this week and is way cheaper than Apple and Microsoft
06-09-2024
September has historically been the worst-performing month for both bitcoin and stocks.
06-09-2024
“She had two rounds of IVF before she had a successful pregnancy. It cost $90,000, which has wiped out most of their savings.”